Browsing Tag
MRSA
5 posts
LABT lists on Nasdaq: Can Lakewood-Amedex Biotherapeutics’ Bisphosphocin class crack antibiotic resistance?
Lakewood-Amedex Biotherapeutics (LABT) lists on Nasdaq with Nu-3 antimicrobial targeting infected diabetic foot ulcers. Read what it means for AMR investors.
Positive IDWeek 2025 results highlight Armata’s AP-SA02 phage cocktail as a potential game-changer for Staph bacteremia
Find out how Armata Pharmaceuticals’ AP-SA02 phage therapy could redefine treatment for Staphylococcus aureus bloodstream infections.
Nano-Mupirocin breakthrough: Revium Rx targets MRSA and VRE with next-generation antibiotic innovation
Find out how Revium Rx’s Nano-Mupirocin could redefine antibiotic therapy against MRSA and VRE and reshape the global antimicrobial resistance market.
Shanghai MicuRx advances MRX-4 trial results towards NDA approval
Shanghai MicuRx Pharmaceutical Co., Ltd. has announced a major breakthrough in antibacterial drug development, successfully completing its Phase…
Sun Pharma introduces STARIZO to tackle drug-resistant skin infections in India
Sun Pharmaceutical Industries Limited has introduced STARIZO (Tedizolid Phosphate) to the Indian market, a novel antibacterial treatment targeting…